<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39425328</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2470-0053</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><Issue>3-1</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Physical review. E</Title><ISOAbbreviation>Phys Rev E</ISOAbbreviation></Journal><ArticleTitle>Pursuing equitable access to vaccines for the next epidemic.</ArticleTitle><Pagination><StartPage>034314</StartPage><MedlinePgn>034314</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1103/PhysRevE.110.034314</ELocationID><Abstract><AbstractText>To mitigate the pandemic stemming from COVID-19, numerous nations have initiated extensive vaccination campaigns for their citizens since late 2020. While affluent countries have predominantly received vaccine allocations, fewer doses have been dispatched to nations with lower average incomes. This unequal distribution not only widens the disparity between wealthy and impoverished regions but also prolongs the pandemic, evident in the emergence of new viral variants. Our research delves into the correlation between the duration of the pandemic and the timing of vaccine distribution between two countries with migratory ties. By using a pair of coupled susceptible-infected-recovered-deceased models incorporating vaccination data, we demonstrate that timely sharing of vaccines benefits both nations, regardless of the presence of viral variants. This underscores that in the realm of vaccine distribution, self-interest and altruism are not mutually exclusive.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chou</LastName><ForeName>Hsin-Ju</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Physics, &lt;a href="https://ror.org/04tsc8g87"&gt;National Kaohsiung Normal University&lt;/a&gt;, Kaohsiung 82444, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Jing-Yuan</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Physics, &lt;a href="https://ror.org/04tsc8g87"&gt;National Kaohsiung Normal University&lt;/a&gt;, Kaohsiung 82444, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Sung-Po</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Physics, &lt;a href="https://ror.org/04tsc8g87"&gt;National Kaohsiung Normal University&lt;/a&gt;, Kaohsiung 82444, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Phys Rev E</MedlineTA><NlmUniqueID>101676019</NlmUniqueID><ISSNLinking>2470-0045</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058872" MajorTopicYN="N">Epidemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39425328</ArticleId><ArticleId IdType="doi">10.1103/PhysRevE.110.034314</ArticleId></ArticleIdList></PubmedData></PubmedArticle>